Literature DB >> 6653614

Metabolism and clearance of proxicromil--studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man.

D A Smith, M G Neale.   

Abstract

Proxicromil was extensively metabolized and eliminated as metabolites in urine and faeces by the rat, hamster, rabbit, squirrel monkey, cynomolgus monkey, baboon and man after oral administration. The pathway of metabolism in these species was by hydroxylation of the alicyclic ring principally to yield monohydroxylated metabolites with trace amounts of a dihydroxylated product. Elimination of proxicromil by the dog, however, was essentially as the unchanged drug. The lack of metabolism of the drug by the dog resulted in the dog having a dependence on biliary excretion of the unchanged drug for clearance. These differences in clearance routes between species were reflected in the plasma clearance of the drug. The value for rat, a species capable of metabolism, was approximately 20 fold (4.1 ml min-1 kg-1) greater than the corresponding value for dog (0.2 ml min-1 kg-1). Inhibiting the metabolism of proxicromil in the rat with SKF-525A lowered plasma clearance of proxicromil (0.6 ml min-1 kg-1) and elevated the proportion of unchanged drug cleared by biliary excretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653614     DOI: 10.1007/BF03188752

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  New orally effective chromosome derivatives for the treatment of asthma.

Authors:  J Augstein; H Cairns; D Hunter; T B Lee; J Suschitzky; R E Altounyan; D M Jackson; J Mann; T S Orr; P Sheard
Journal:  Agents Actions       Date:  1977-10

2.  Metabolic and pharmacokinetic study of bucloxic acid. I. Isolation and identification of the main excretion products in animals and in man.

Authors:  P M Gros; H J Davi; L F Chasseaud; D R Hawkins
Journal:  Arzneimittelforschung       Date:  1974-09

Review 3.  The concept of regioselectivity in drug metabolism.

Authors:  B Testa; B Jenner
Journal:  J Pharm Pharmacol       Date:  1976-10       Impact factor: 3.765

4.  Metabolism of tetralin and toxicity of Cuprex in man.

Authors:  D E Drayer; M M Reidenberg
Journal:  Drug Metab Dispos       Date:  1973 May-Jun       Impact factor: 3.922

5.  Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation.

Authors:  P G Dayton; J M Perel; R F Cunningham; Z H Israili; I M Weiner
Journal:  Drug Metab Dispos       Date:  1973 Nov-Dec       Impact factor: 3.922

6.  The metabolism of the neuroleptic agent 1 (4'-fluorophenyl)-4-(cyclohexyl-1'-piperzinyl-4'-carboxylated)-butan-1-one hydrochloride in rats and man.

Authors:  D R Hawkins; D H Moore; L F Chasseaud
Journal:  Xenobiotica       Date:  1977-05       Impact factor: 1.908

7.  Dihydroxylated metabolites of cannabinol formed by rat liver in vitro.

Authors:  K Fonseka; M Widman
Journal:  J Pharm Pharmacol       Date:  1977-01       Impact factor: 3.765

8.  The metabolism of tetralin.

Authors:  T H Elliott; J Hanam
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

9.  Metabolism and urinary excretion of benzhexol in humans.

Authors:  R L Nation; E J Triggs; J Vine
Journal:  Xenobiotica       Date:  1978-03       Impact factor: 1.908

10.  Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes.

Authors:  H E May; R Boose; D J Reed
Journal:  Biochem Biophys Res Commun       Date:  1974-03-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.